Covaxin Patent Issue: Bharat Biotech to Credit ICMR
Bharat Biotech admits patent oversight on Covaxin, pledges to include ICMR scientists in new filings to uphold transparency and legal ...
- Latest
- Trending
Bharat Biotech admits patent oversight on Covaxin, pledges to include ICMR scientists in new filings to uphold transparency and legal ...
US sanctions 12 Kaspersky Lab execs over Russia ties; bans software sales and updates in the US, urging users to ...
"US bans Russian cybersecurity software Kaspersky over national security concerns and alleged influence operations, effective Sept. 30."
US to ban Kaspersky antivirus over national security risks, citing alleged Russian ties. Move prevents sales, aims to protect infrastructure.
Trinity Biotech plc gets a "buy" rating from StockNews.com analysts, spotlighting potential for investors with a focus on its diagnostic ...
Rider data compromised in TheBus and Handi-Van ransomware attack; OTS investigates, services disrupted but routes still operational, recovery ongoing.
Iovance Biotherapeutics has the potential to become a multiproduct company, and even if its stock doesn't soar quickly, it's still ...
Researchers have successfully developed a single-dose vaccine that prompts the production of T-cells and "memory" B cells to fight against ...
Teladoc Health's revenue grew by 8% to $2.6 billion in 2023, with a gross margin of 70.8%. On the other ...
Pfizer and Moderna have struggled in the stock market, but Pfizer has a substantial pipeline of programs. Moderna's success is ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.